- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Advances in Pharmacological Sciences
Volume 2013 (2013), Article ID 506191, 7 pages
Dehydroepiandrosterone Stimulates Nerve Growth Factor and Brain Derived Neurotrophic Factor in Cortical Neurons
1Stem Cell and Tissue Engineering Department, Research Center for Science and Technology in Medicine (RCSTiM), Tehran University of Medical Sciences, Tehran 19988-96953, Iran
2Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran 19988-96953, Iran
3Rajaie Cardiovascular, Medical and Research Centre, Iran University of Medical Sciences, Tehran 19969-14151, Iran
4Faculty of Medicine, Islamic Azad University of Mashhad, Mashhad 91779-48564, Iran
Received 13 August 2013; Revised 15 October 2013; Accepted 15 October 2013
Academic Editor: Karim A. Alkadhi
Copyright © 2013 Anahita Rahmani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. R. Berkemeier, J. W. Winslow, D. R. Kaplan, K. Nikolics, D. V. Goeddel, and A. Rosenthal, “Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB,” Neuron, vol. 7, no. 5, pp. 857–866, 1991.
- M. Noureddini, J. Verdi, S. A. Mortazavi Tabatabaei, S. Sharif, and A. Shoae-Hassani, “Human endometrial stem cell neurogenesis in response to NGF and bFGF,” Cell Biology International, vol. 36, pp. 961–966, 2012.
- R. Levi-Montalcini, “The nerve growth factor: thirty-five years later,” The EMBO Journal, vol. 6, no. 5, pp. 1145–1154, 1987.
- A. M. Davies, “The role of neurotrophins in the developing nervous system,” Journal of Neurobiology, vol. 25, no. 11, pp. 1334–1348, 1994.
- S. Ahmed, B. A. Reynolds, and S. Weiss, “BDNF enhances the differentiation but not the survival of CNS stem cell-derived neuronal precursors,” The Journal of Neuroscience, vol. 15, no. 8, pp. 5765–5778, 1995.
- N. A. Compagnone and S. H. Mellon, “Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 8, pp. 4678–4683, 1998.
- A. Shoae-Hassani, S. A. Mortazavi-Tabatabaei, S. Sharif, H. Rezaei-Khaligh, and J. Verdi, “DHEA provides a microenvironment for endometrial stem cells neurogenesis,” Medical Hypotheses, vol. 76, no. 6, pp. 843–846, 2011.
- V. G. Kimonides, N. H. Khatibi, C. N. Svendsen, M. V. Sofroniew, and J. Herbert, “Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 4, pp. 1852–1857, 1998.
- S. Bastianetto, C. Ramassamy, J. Poirier, and R. Quirion, “Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage,” Molecular Brain Research, vol. 66, no. 1-2, pp. 35–41, 1999.
- V. G. Kimonides, M. G. Spillantini, M. V. Sofroniew, J. W. Fawcett, and J. Herbert, “Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures,” Neuroscience, vol. 89, no. 2, pp. 429–436, 1999.
- M. Chopp and Y. Li, “Treatment of neural injury with marrow stromal cells,” The Lancet Neurology, vol. 1, no. 2, pp. 92–100, 2002.
- M. Durand, S. Aguerre, F. Fernandez et al., “Strain-dependent neurochemical and neuroendocrine effects of desipramine, but not fluoxetine or imipramine, in Spontaneously Hypertensive and Wistar-Kyoto rats,” Neuropharmacology, vol. 39, no. 12, pp. 2464–2477, 2000.
- S. Tejani-Butt, J. Kluczynski, and W. P. Paré, “Strain-dependent modification of behavior following antidepressant treatment,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 27, no. 1, pp. 7–14, 2003.
- C. C. Will, F. Aird, and E. E. Redei, “Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants,” Molecular Psychiatry, vol. 8, no. 11, pp. 925–932, 2003.
- O. Malkesman, T. Asaf, L. Shbiro et al., “Monoamines, BDNF, dehydroepiandrosterone, DHEA-Sulfate, and childhood depression: an animal model study,” Advances in Pharmacological Sciences, vol. 2009, Article ID 405107, 11 pages, 2009.
- R. N. Pechnick, S. Zonis, K. Wawrowsky, J. Pourmorady, and V. Chesnokova, “p21Cip1 restricts neuronal proliferation in the subgranular zone of the dentate gyrus of the hippocampus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 4, pp. 1358–1363, 2008.
- R. Maayan, O. Morad, P. Dorfman, D. H. Overstreet, A. Weizman, and G. Yadid, “The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression,” European Neuropsychopharmacology, vol. 15, no. 3, pp. 253–262, 2005.
- Y. A. Barde, D. Edgar, and H. Thoenen, “Purification of a new neurotrophic factor from mammalian brain,” The EMBO Journal, vol. 1, no. 5, pp. 549–553, 1982.
- A. Rahmani, D. Kheradmand, P. Keyhanvar, A. Shoae-Hassani, and A. Darbandi-Azar, “Neurogenesis and increase in differentiated neural cell survival via phosphorylation of Akt1 after fluoxetine treatment of stem cells,” BioMed Research International, vol. 2013, Article ID 582526, 9 pages, 2013.
- K. K. Karishma and J. Herbert, “Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression,” European Journal of Neuroscience, vol. 16, no. 3, pp. 445–453, 2002.
- M. Suzuki, L. S. Wright, P. Marwah, H. A. Lardy, and C. N. Svendsen, “Mitotic neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived the fetal cortex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 3202–3207, 2004.
- A. Shoae-Hassani, S. Sharif, and J. Verdi, “The neurosteroid dehydroepiandrosterone could improve somatic cell reprogramming,” Cell Biology International, vol. 35, no. 10, pp. 1037–1041, 2011.
- M. A. I. Åberg, N. D. Åberg, H. Hedbäcker, J. Oscarsson, and P. S. Eriksson, “Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus,” The Journal of Neuroscience, vol. 20, no. 8, pp. 2896–2903, 2000.
- A. J. Morales, J. J. Nolan, J. C. Nelson, and S. S. C. Yen, “Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age,” Journal of Clinical Endocrinology and Metabolism, vol. 78, pp. 1360–1367, 1994.
- I. Charalampopoulos, V. Alexaki, C. Tsatsanis et al., “Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging,” Annals of the New York Academy of Sciences, vol. 1088, pp. 139–152, 2006.
- M. Korte, H. Kang, T. Bonhoeffer, and E. Schuman, “A role for BDNF in the late-phase of hippocampal long-term potentiation,” Neuropharmacology, vol. 37, no. 4-5, pp. 553–559, 1998.
- D. Lindholm, E. Castren, M. Berzaghi, A. Blochl, and H. Thoenen, “Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain: implications for neuronal plasticity,” Journal of Neurobiology, vol. 25, no. 11, pp. 1362–1372, 1994.
- E. M. Gubba, J. W. Fawcett, and J. Herbert, “The effects of corticosterone and dehydroepiandrosterone on neurotrophic factor mRNA expression in primary hippocampal and astrocyte cultures,” Molecular Brain Research, vol. 127, no. 1-2, pp. 48–59, 2004.
- I. Lazaridis, I. Charalampopoulos, V. Alexaki et al., “Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis,” PLoS Biology, vol. 9, no. 4, Article ID e1001051, 2011.
- T. M. Pham, B. Ickes, D. Albeck, S. Söderström, A.-C. Granholm, and A. H. Mohammed, “Changes in brain nerve growth factor levels and nerve growth factor receptors in rats exposed to environmental enrichment for one year,” Neuroscience, vol. 94, no. 1, pp. 279–286, 1999.